Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Amy GilesIncreasing Engagement
Frank BurrellScientific Storytelling
Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
David LinetskyPoint-of-Care Marketing
Bud BilanichSuccess Coach
Joey CohenMedication Adherence
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email